RHEA Nehru SUBBA

Ms. RHEA Nehru SUBBA


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2022 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SASurendra Kumar Anand
Surendra Kumar Anand
MAMir Hilal Ahmad
Mir Hilal Ahmad
MSManas Ranjan Sahu
Manas Ranjan Sahu
RSRHEA Nehru SUBBA
RHEA Nehru SUBBA
Amal Chandra MondalAmal Chandra Mondal
Amal Chandra Mondal

2 May 2022 in European Journal of Pharmacology
Verified
Journal Article
Closed access
RSRHEA Nehru SUBBA
RHEA Nehru SUBBA
MAMir Hilal Ahmad
Mir Hilal Ahmad
BGBalaram Ghosh
Balaram Ghosh
Amal Chandra MondalAmal Chandra Mondal
Amal Chandra Mondal

21 November 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
RSRHEA Nehru SUBBA
RHEA Nehru SUBBA
Gianluca FascioloGianluca Fasciolo
Gianluca Fasciolo
APAdriana Petito
Adriana Petito
Eugenio GeremiaEugenio Geremia
Eugenio Geremia
Maria Teresa Muscari TomajoliMaria Teresa Muscari Tomajoli
Maria Teresa Muscari Tomajoli
Paola VendittiPaola Venditti
Paola Venditti
Oxidative stress is a key contributor to diabetes-related cognitive decline and is intensified by diabetes distress (DD), the psychological burden of disease management. DD lowers brain levels of nuclear factor erythroid 2-related factor 2 (NRF2), a transcription factor that regulates antioxidant defense. This study examined whether chlorogenic acid (CGA), a polyphenolic NRF2 activator, could counteract oxidative and astroglial dysfunctions in adult zebrafish subjected to chronic unpredictable mild stress (CUMS) combined with dextrose, a model mimicking DD. Zebrafish were treated with CGA (50, 100, or 200 mg/kg), and the levels of NRF2 protein and mRNA, along with its regulator keap1, were quantified. Expression levels of key downstream antioxidant genes (sod1, sod2, catalase, glutathione peroxidase, and glutamate-cysteine ligase catalytic subunit) were assessed alongside glutathione (GSH) content and superoxide dismutase (SOD) and catalase activities. Astroglial integrity was evaluated via glial fibrillary acidic protein (GFAP) levels in the whole brain and stress-sensitive regions. CGA increased total brain NRF2 protein, its mRNA, and those of its downstream effectors. At 200 mg/kg, CGA restored GSH levels, boosted antioxidant enzyme activities, and mitigated DD-associated reductions in GFAP and NRF2 in stress-vulnerable areas. These findings identify NRF2 as a promising target to protect brain health under diabetic conditions.